Home
|
Show All
|
Simple Search
|
Advanced Search
Login Admin Infodrog
Quick Search:
Field:
main fields
author
title
publication
year
keywords
publisher
call_number
notes
contains:
1–1 of 1 record found matching your query (
RSS
|
history
):
Search & Display Options
Search within Results:
Field:
author
title
year
keywords
abstract
type
publication
abbrev_journal
volume
issue
pages
thesis
publisher
place
editor
series_title
language
area
notes
call_number
serial
contains:
Exclude matches
Display Options:
Field:
all fields
keywords & abstract
additional fields
records per page
Select All
Deselect All
<<
1
>>
List View
|
Citations
|
Details
Record
Links
Author
Bousingen, Denis Durand de
Title
Drug firm compensates patients for suspected hepatitis B vaccine failure
Type
Journal Article
Year
2001
Publication
The Lancet
Abbreviated Journal
Volume
357
Issue
19.05.2001
Pages
1598
Keywords
health promotion; viral hepatitis; hepatitis B
Abstract
A French appeal court has ordered GlaxoSmithKline (GSK) to pay US$6686 and US$10 697 in compensation to two women with multiple sclerosis who claim the chronic disease was caused by a hepatitis B vaccine (Engerix B) manufactured by the pharmaceutical company.
Address
Corporate Author
Thesis
Publisher
Place of Publication
Editor
Language
English
Summary Language
Original Title
Series Editor
Series Title
Abbreviated Series Title
Series Volume
Series Issue
Edition
ISSN
0140-6736
ISBN
Medium
Area
Expedition
Conference
Notes
Approved
no
Call Number
50-02698
Serial
59735
Permanent link to this record
Select All
Deselect All
<<
1
>>
List View
|
Citations
|
Details
Home
Show Record
|
Extract Citations
